AB69627
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1g | 98% | in stock | $8.00 | $5.00 | - + | |
5g | 98% | in stock | $15.00 | $11.00 | - + | |
10g | 98% | in stock | $19.00 | $14.00 | - + | |
25g | 98% | in stock | $40.00 | $28.00 | - + | |
100g | 98% | in stock | $159.00 | $112.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AB69627 |
Chemical Name: | 6,8-Dibromoimidazo[1,2-a]pyrazine |
CAS Number: | 63744-22-9 |
Molecular Formula: | C6H3Br2N3 |
Molecular Weight: | 276.91612 |
MDL Number: | MFCD08460056 |
SMILES: | Brc1cn2ccnc2c(n1)Br |
Complexity: | 155 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
XLogP3: | 2.7 |
6,8-Dibromoimidazo[1,2-a]pyrazine is a versatile building block in chemical synthesis, widely used in the pharmaceutical and materials science industries. Due to its unique structure and reactivity, this compound serves as a key intermediate in the synthesis of various biologically active molecules and advanced materials.In organic synthesis, 6,8-Dibromoimidazo[1,2-a]pyrazine acts as a valuable starting material for the construction of complex heterocyclic compounds. Its bromine groups can undergo diverse functional group transformations, including cross-coupling reactions, nucleophilic substitution, and metal-catalyzed cyclization reactions. This enables chemists to efficiently access a wide range of novel compounds with potential applications in drug discovery and material design.Moreover, the imidazo[1,2-a]pyrazine scaffold present in this molecule imparts desirable properties to the synthesized products, such as enhanced biological activity or optoelectronic performance. By strategically incorporating 6,8-Dibromoimidazo[1,2-a]pyrazine into molecular frameworks, researchers can modulate the physicochemical characteristics of the final compounds, opening up new opportunities for developing innovative materials and pharmaceuticals.